Page 117 - Read Online

Mathew et al. Vessel Plus 2020;4:11 I http://dx.doi.org/10.20517/2574-1209.2019.35 Page 13 of 15

60. Holme PA, Orvim U, Hamers MJ, Solum NO, Brosstad FR, et al. Shear-induced platelet activation and platelet microparticle formation at
blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol 1997;17:646-53.
61. Weber A, Köppen HO, Schrör K. Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-
independent mechanism. Thromb Res 2000;98:461-6.
62. Oggero S, Austin-Williams S, Norling LV. The contrasting role of extracellular vesicles in vascular inflammation and tissue repair. Front
Pharmacol 2019;10:1479.
63. Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, Mostefai HA, Draunet-Busson C, et al. Endothelial dysfunction caused by circulating
microparticles from patients with metabolic syndrome. Am J Pathol 2008;173:1210-9.
64. Ettelaie C, Su S, Li C, Collier ME. Tissue factor-containing microparticles released from mesangial cells in response to high glucose and
AGE induce tube formation in microvascular cells. Microvasc Res 2008;76:152-60.
65. Latifkar A, Hur YH, Sanchez JC, Cerione RA, Antonyak MA. New insights into extracellular vesicle biogenesis and function. J Cell Sci
2019;132:jcs222406.
66. Bebelman MP, Smit MJ, Pegtel DM, Baglio SR. Biogenesis and function of extracellular vesicles in cancer. Pharmacol Ther 2018;188:1-11.
67. Dorai T, Shah A, Summers F, Mathew R, Huang J, et al. NRH:Quinone Oxidoreductase 2 (NQO2) and Glutaminase (GLS) both play a
role in large extracellular vesicles (LEV) formation in preclinical LNCaP-C4-2B prostate cancer model of progressive metastasis. Prostate
2018;78:1181-95.
68. Kassem M, Kristiansen M, Abdallah BM. Mesenchymal stem cells: cell biology and potential use in therapy. Basic Clin Pharmacol
Toxicol 2004;95:209-14.
69. Li L, Wang R, Jia Y, Rong R, Xu M, et al. Exosomes derived from mesenchymal stem cells ameliorate renal ischemic-reperfusion
injurythrough inhibiting inflammation and cell apoptosis. Front Med 2019;6:269.
70. Song YS, Joo HW, Park IH, Shen GY, Lee Y, et al. Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor
attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction. PLoS One
2017;12:e0179972.
71. Zhou Z, Pan M, Yan C. Mesenchymal stem cells transfer mitochondria into cerebral microvasculature and promote recovery from
ischemic stroke. Microvasc Res 2019;123:74-80.
72. Sun Y, Shi H, Yin S, Ji C, Zhang X, et al. Human mesenchymal stem cell derived exosomes alleviate type 2 diabetes mellitus by reversing
peripheral insulin resistance and relieving β-cell destruction. ACS Nano 2018;12:7613-628.
73. Qiu G, Zheng G, Ge M, Wang J, Huang R, et al. Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via
transfer of microRNAs. Stem Cell Res Therap 2018;9:320.
74. Lai RC, Yeo RW, Lim SK. Mesenchymal stem cell exosomes. Semin Cell Dev Biol 2015;40:82-8.
75. Arslan F, Lai RC, Smeets MB, Akeroyd L, Choo A, et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease
oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial
ischemia/reperfusion injury. Stem Cell Res 2013;10:301-12.
76. Salomon C, Ryan J, Sobrevia L, Kobayashi M, Ashman K, et al. Exosomal signaling during hypoxia mediates microvascular endothelial
cell migration and vasculogenesis. PLoS One 2013;8:e68451.
77. Sammour I, Somashekar S, Huang J, Batlahally S, Breton M, et al. The effect of gender on mesenchymal stem cell (MSC) efficacy in
neonatal hyperoxia-induced lung injury. PloS One 2016;11:e0164269.
78. Zeller CN, Wang Y, Markel TA, Weil B, Abarbanell A, et al. Role of tumor necrosis factor receptor 1 in sex differences of stem cell
mediated cardioprotection. Ann Thorac Surg 2009;87:812-9.
79. Wang L, Gu H, Turrentine M, Wang M. Estradiol treatment promotes cardiac stem cell (CSC)-derived growth factors, thus improving
CSC-mediated cardioprotection after acute ischemia/reperfusion. Surgery 2014;156:243-52.
80. Matsumoto T, Kubo S, Meszaros LB, Corsi KA, Cooper GM, et al. The influence of sex on the chondrogenic potential of muscle-derived
stem cells: implications for cartilage regeneration and repair. Arthritis Rheum 2008;58:3809-19.
81. Mause SF, von Hundelshausen P, Zernecke A, Koenen RR, Weber C. Platelet microparticles: a transcellular delivery system for RANTES
promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 2005;25:1512-8.
82. Blair LA, Haven AK, Bauer NN. Circulating microparticles in severe pulmonary arterial hypertension increase intercellular adhesion
molecule-1 expression selectively in pulmonary artery endothelium. Respir Res 2016;17:133.
83. Nadaud S, Poirier O, Girerd B, Blanc C, Montani D, et al. Small platelet microparticle levels are increased in pulmonary arterial
hypertension. Eur J Clin Invest 2013;43:64-71.
84. Diehl P, Aleker M, Helbing T, Sossong V, Germann M, et al. Increased platelet, leukocyte and endothelial microparticles predict enhanced
coagulation and vascular inflammation in pulmonary hypertension. J Thromb Thrombolysis 2011;31:173-9.
85. Amabile N, Heiss C, Chang V, Angeli FS, Damon L, et al. Increased CD62e (+) endothelial microparticle levels predict poor outcome in
pulmonary hypertension patients. J Heart Lung Transplant 2009;28:1081-6.
86. Tual-Chalot S, Guibert C, Muller B, Savineau JP, Andriantsitohaina R, et al. Circulating microparticles from pulmonary hypertensive rats
induce endothelial dysfunction. Am J Respir Crit Care Med 2010;182:261-8.
87. Bakouboula B, Morel O, Faure A, Zobairi F, Jesel L, et al. Procoagulant membrane microparticles correlate with the severity of
pulmonary arterial hypertension. Am J Respir Crit Care Med 2008;177:536-43.
88. Kosanovic D, Deo U, Gall H, Selvakumar B, Herold S, et al. Enhanced circulating levels of CD3 cells-derived extracellular vesicles in
different forms of pulmonary hypertension. Pulm Circ 2019;9:2045894019864357.
89. Zhao L, Luo H, Li X, Li T, He J, et al. Exosomes derived from human pulmonary artery endothelial cells shift the balance between